Looking to Acquire: US or Canada-Based Parenterals Manufacturing Facility

Our Asian client is looking to acquire a parenterals manufacturing facility in the US or Canada. 

Our client is currently developing an innovative, first-in-class, small molecule drug candidate. Phase III trials are in the planning stages. 

As part of their go-to-market strategy, the company wishes to establish their own manufacturing center in North America. This will enable the company to manufacture and distribute clinical- and commercial-scale product for North America, and possible other parts of the World. 

Requirements

Key requirements include:

  • FDA approved facility
  •  Currently manufacturing and shipping parenteral products (vials, ampules, pre-filled syringes, etc.)
  • Must be manufacturing products containing small molecule drugs
  • Space for additional manufacturing of high-volume vial-based parenteral product(s)
  • Preference for facilities or companies with positive cash flow

Our client would consider acquiring an individual site or an entire company, provided the latter is relatively small. 

Please fill out the form below if you have any leads which may fit our criteria.